Breast Cancer Radiation Treatments – Single Dose Treatment for Breast Cancer

A new Breast Cancer Radiation Treatments results were published in The Lancet medical journal indicating that single dose of radiation treatment for breast cancer during surgery is just as efficient for breast cancer patients compared to those receiving weeks of radiation.

Over 2,000 women from 9 countries in Europe, North America and Asia participated in the test, in which a one-time blast radiation or was directed at a tumor location during surgery. The test presented that four years after this single dose radiation treatment for breast cancer, the chances of having a recurrence of breast cancer was almost the same for both radiation treatments.

Applying the single dose procedure would be more convenient for patients and also greatly cut down the waiting lists. It is the next step in opening up a wider range of alternatives for women. These new treatment technique could save patients weeks of after operation radiotherapy that can lead to 20 or 30 visits to hospital. The single dose breast cancer radiation treatment during surgery also prevents possible harm from radiation exposure to organs such as the heart, lung, and oesophagus.

These new technique is called the Targets Intra-operative Radiotherapy, whereby a mobile radiotherapy machine is used to insert into the breast to direct the exact locate of the breast cancer. However, the major drawback is that while the study followed women for four years after their cancer was diagnosed, the disease can sometimes recur after eight or more years. Also, the findings were only applicable to women with a same type of breast cancer as those in the test but still researchers were excited about the findings.

Radiotherapy is already a very effective treatment, so improving it even further is an exciting prospect. Additional follow-up on these women will be required to affirm whether this breast cancer radiation treatment is not only makes the most of the therapy’s power but also reduces any long-term side effects.